Elutia (Nasdaq: ELUT) announced inducement equity awards granted March 10, 2026 to three new employees under its 2026 Inducement Award Plan.
An aggregate of 460,000 non-qualified stock options were granted with a $1.09 exercise price (closing price on March 10, 2026). Options vest 25% after one year, then monthly over three years, subject to continued employment and plan terms.
Loading...
Loading translation...
Positive
None.
Negative
None.
News Market Reaction – ELUT
-6.09%
2 alerts
-6.09%Session close to close
$45.58MMarket Cap
0.6xRel. Volume
In the Mar 13 session, ELUT declined 6.09%, reflecting a notable negative market reaction.
Our momentum scanner triggered 2 alerts that day, indicating moderate trading interest and price volatility.
The stock moved -6.1% in the session following this news. A negative reaction despite this routine i...
Analysis
The stock moved -6.1% in the session following this news. A negative reaction despite this routine inducement grant would fit a pattern where some positive updates saw short-term weakness, as with prior leadership and compliance news. The options, totaling 460,000 at an exercise price of $1.09, reflect standard hiring-related equity and do not change the fundamental trajectory established by recent earnings and regulatory milestones. Any sharp decline could therefore reflect broader positioning or profit-taking rather than this administrative action alone.
Key Figures
Inducement options granted:460,000 optionsNew employees:3 employeesInitial vesting tranche:25%+3 more
6 metrics
Inducement options granted460,000 optionsAggregate non-qualified stock options granted to three new employees
New employees3 employeesRecipients of inducement awards under the 2026 Inducement Award Plan
Initial vesting tranche25%Options vest 25% on first anniversary of vesting commencement date
Remaining vesting period3 yearsBalance vests in equal monthly installments over next three years
Exercise price$1.09 per shareExercise price equals Elutia closing price on March 10, 2026 grant date
Grant dateMarch 10, 2026Date equity inducement awards were approved and granted
Received 2026 Great Place to Work Certification highlighting culture and tenure.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Pattern Detected
Recent news has generally been positive, with mixed immediate price reactions—some strategic and compliance updates drew gains, while certain positive operational milestones saw short-term pullbacks.
Recent Company History
Over the past month, Elutia reported Q4 and full-year 2025 results and initiated regulatory steps for NXT-41, highlighted by an $88.0M BioEnvelope sale and elimination of long-term debt. The company regained full Nasdaq listing compliance and added a Chief Commercial Officer to prepare for anticipated 2027 NXT-41x clearance. Culture and workplace recognition rounded out the news flow. The current inducement option grants fit into this broader phase of balance sheet repair, governance, and commercialization build-out.
"received an aggregate of 460,000 non-qualified stock options (the “Options”)."
Non-qualified stock options are a type of employee benefit that gives individuals the right to buy company shares at a set price, usually lower than the market value, within a certain period. Unlike other options that may have special tax advantages, these options are taxed as income when exercised, which can affect how much money the employee or investor ultimately gains. They are important because they can influence company compensation strategies and impact the financial outcomes for employees and investors.
nasdaq listing rule 5635(c)(4)regulatory
"were granted in accordance with Nasdaq Listing Rule 5635(c)(4)."
NASDAQ Listing Rule 5635(c)(4) is a rule that requires a company to get approval from its shareholders before selling a large amount of its shares, usually over 20%. This helps protect investors by making sure the company doesn't flood the market with new shares without their say, which could lower the stock's value.
vesting commencement datetechnical
"vest 25% on the first anniversary of the vesting commencement date, with the balance"
The vesting commencement date is the starting point when an employee begins earning ownership rights to their promised benefits, such as stock options or retirement contributions. Think of it like the day a savings account is opened—only after this date do the benefits start to grow and become fully available over time. It matters to investors because it marks when the clock begins ticking toward full ownership, affecting the timing and value of these benefits.
exercise pricefinancial
"The Options have an exercise price of $1.09 per share, the closing price of Elutia’s"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
GAITHERSBURG, Md., March 13, 2026 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) ("Elutia" or the "Company"), a pioneer in drug-eluting biomatrix technologies, today announced that it granted equity awards on March 10, 2026 to three new employees as inducement awards under the Elutia Inc. 2026 Inducement Award Plan (the “Plan”). The awards were approved by the independent Compensation Committee of the Board of Directors, and were granted in accordance with Nasdaq Listing Rule 5635(c)(4).
Under the Plan, the three new employees received an aggregate of 460,000 non-qualified stock options (the “Options”). The Options vest 25% on the first anniversary of the vesting commencement date, with the balance vesting in equal monthly installments over the following three years. Vesting is subject to each recipient’s continued employment through the applicable vesting date. The Options have an exercise price of $1.09 per share, the closing price of Elutia’s common stock on the Nasdaq Capital Market on March 10, 2026, the grant date. The Options are subject to the terms and conditions of the Plan and the applicable stock option agreement.
About Elutia
Elutia develops and commercializes drug-eluting biomatrix products to improve compatibility between medical devices and the patients who need them. With a growing population in need of implantable technologies, Elutia’s mission is humanizing medicine so patients can thrive without compromise. For more information, visit www.Elutia.com.
What inducement awards did Elutia (ELUT) grant on March 10, 2026?
Elutia granted an aggregate of 460,000 non-qualified stock options to three new employees. According to Elutia, the grants were made under the 2026 Inducement Award Plan and approved by the independent Compensation Committee.
What is the vesting schedule for the ELUT inducement options granted March 10, 2026?
The options vest 25% on the first anniversary, then monthly over three years thereafter. According to Elutia, vesting is conditioned on each recipient's continued employment through each vesting date.
What exercise price was set for ELUT options granted March 10, 2026?
The exercise price is $1.09 per share, equal to the closing Nasdaq price on March 10, 2026. According to Elutia, that closing price determined the grant-date exercise price for the options.
Why were the ELUT awards granted under Nasdaq Listing Rule 5635(c)(4)?
The grants were executed as inducement awards in reliance on Nasdaq Listing Rule 5635(c)(4). According to Elutia, the independent Compensation Committee approved the awards consistent with that Nasdaq rule.
How might the 460,000 ELUT option grants affect existing shareholders?
The grants create potential future dilution if exercised, increasing share count upon exercise. According to Elutia, theOptions are subject to exercise and plan terms; the company did not disclose expected dilution percentage.
